Many epidemiologic studies have demonstrated consistent associations between exposure to airborne particulate matter (PM) and increased risks of morbidity and mortality \[[@b3-ehp0114-001215]; [@b36-ehp0114-001215]\]. Risks of premature mortality appear to be greatest among older adults with preexisting cardiac and respiratory conditions, especially ischemic heart disease and chronic obstructive pulmonary disease (COPD). However, underlying pathophysiologic mechanisms are still unknown. It is plausible that PM-associated mortality can be explained, at least in part, by alterations in cardiac autonomic balance, as measured by heart rate variability (HRV).

HRV describes changes in consecutive sinus R-R intervals or in instantaneous heart rates recorded on an electrocardiogram (ECG) and has been associated with all-cause mortality ([@b35-ehp0114-001215]), sudden cardiac death ([@b1-ehp0114-001215]), and death due to heart failure ([@b32-ehp0114-001215]). HRV is decreased in survivors of acute myocardial infarction compared with healthy subjects ([@b4-ehp0114-001215]) and is altered in smokers ([@b13-ehp0114-001215]) and in individuals with COPD ([@b22-ehp0114-001215]). Decreased HRV has also been linked with conditions involving autonomic nervous system dysfunction, such as diabetes ([@b24-ehp0114-001215]) and Parkinson disease ([@b15-ehp0114-001215]).

Several studies have linked exposure to ambient PM with decreased HRV ([@b9-ehp0114-001215]; [@b11-ehp0114-001215]; [@b14-ehp0114-001215]; [@b16-ehp0114-001215]; [@b23-ehp0114-001215]; [@b27-ehp0114-001215], [@b26-ehp0114-001215]; [@b30-ehp0114-001215]). These investigations were conducted in areas where the mass of PM with aerodynamic diameter ≤ 10 μm (PM~10~) was composed primarily of fine particles \[PM with aerodynamic diameter ≤ 2.5 μm (PM~2.5~)\], which typically originate in combustion and photo-chemical processes. In contrast, coarse particles \[PM with aerodynamic diameter between 2.5 and 10 μm (PM~10--2.5~)\] are primarily derived from soil and from abrasive mechanical processes in transportation and industry ([@b36-ehp0114-001215]). At least two studies found no relationship between PM~10--2.5~ and changes in HRV ([@b11-ehp0114-001215]; [@b16-ehp0114-001215]); however, those investigations took place in urban areas with low PM~10--2.5~ levels. In contrast, our study is the first to examine the impact of PM on HRV in an area where PM~10--2.5~ predominates.

We previously identified associations between daily PM~10~ concentrations and cardiovascular mortality in Coachella Valley, a desert resort and retirement area east of Los Angeles, California ([@b21-ehp0114-001215], [@b20-ehp0114-001215]). Within this valley, widespread gusty winds occur in conjunction with large pressure gradients resulting from differences between the desert and coastal air masses, generating copious quantities of windblown sand and dust. Most of the variability in PM~10~ in the valley is attributable to PM~10--2.5~, even on days without wind events. Based on concurrent PM~10~ and PM~2.5~ fixed-site monitoring during a 2.5-year period, PM~10--2.5~ was highly correlated with PM~10~ on a daily basis (*r* \~ 0.95) ([@b20-ehp0114-001215]). Chemical mass balance modeling undertaken by the South Coast Air Quality Management District ([@b28-ehp0114-001215]) indicated that geologic sources contribute approximately 50--60% of PM~10~ on an annual basis and up to 95% during wind events. In the present study, we examined whether ambient PM~10~, PM~2.5~, and PM~10--2.5~ levels were associated with changes in HRV in older adults with coronary artery disease.

Materials and Methods
=====================

Subject recruitment
-------------------

The study protocol was approved by the Institutional Review Board of the Public Health Institute (Oakland, California). Study participants were recruited from a large cardiology practice and through newspaper advertisements from December 1999 through February 2000. Subjects were eligible if they were ambulatory adults ≥ 60 years of age; were not current smokers; had coronary artery disease manifested by at least one of the following: *a*) a history of angina and a positive ECG, echocardiographic or nuclear stress test, or angiography (*n* = 12), *b*) prior percutaneous coronary intervention (*n* = 1), *c*) prior coronary artery bypass surgery (*n* = 12), or *d*) a history of myocardial infarction at least 6 months before recruitment (*n* = 16) (of the 19 subjects in the study, almost all met at least two criteria for eligibility); and residence within 5 miles of either of the two fixed-site air quality monitoring stations in Coachella Valley (located in Palm Springs and Indio).

Exclusion criteria included conditions associated with autonomic dysfunction (e.g., diabetes, chronic renal failure, Parkinsonism, and chronic alcohol abuse), cardiac transplant, cardiac pacemaker, implantable defibrillator, atrial fibrillation, or significant cognitive impairment.

Data collection
---------------

During the initial in-person appointment, staff obtained written informed consent and administered a baseline questionnaire, which included questions on subject demographics, medical history, current medications, usual daily activities, and any limitations on activity. The information obtained in the baseline questionnaire was supplemented by abstracting photocopies of the individuals' medical records on standardized forms. Data abstracted from the medical records included, where available, left ventricular ejection fraction (LVEF), history of myocardial infarction, and medications prescribed. During this study, the participants remained under the medical supervision of their regular personal physicians.

Staff also measured the subjects' lung function at baseline using a portable Simplicity spirometer (Mallinckrodt, Inc., St. Louis, MO). Spirometry was conducted following the guidelines of the [@b2-ehp0114-001215], with reproducibility criteria modified slightly to accommodate the subjects' ages (i.e., results of at least three of the forced expiratory maneuvers were required to be within 15% of one another). Briefly, the subjects were seated and wore a nose clip for the spirometric maneuvers. Each subject performed at least four expiratory maneuvers. Spirometry was rescheduled for subjects who reported a respiratory infection in the preceding 3 weeks.

Twenty-four--hour ambulatory ECGs were digitally recorded for each subject at weekly intervals from 14 February through 31 May 2000, using lightweight Trillium 3000 Holter monitors with disposable electrodes (Forest Medical, Syracuse, NY). During the Holter monitoring, subjects performed their normal daily activities, except those that would interfere with the ECG recording, such as showering. In general, Holter monitoring began at the same time and day every week for each subject. In cases of missed appointments, subjects were rescheduled for monitoring within the next 2 days, if possible.

Staff followed a standardized protocol for subject preparation and placed five electrodes (two channels) in a modified V5 and aVF configuration similar to that used by [@b27-ehp0114-001215], [@b26-ehp0114-001215]). Each Holter monitoring session began with a 20-min resting ECG with the subject supine, during which staff remained with the subject. At each session, staff gave the subject a simple 24-hr time--activity diary to record times spent indoors or outdoors, air conditioner (AC) use (yes or no), and whether windows were open during each 2-hr period (and one 6-hr block from 2400 hr to 0600 hr).

Staff downloaded each subject's monitoring data from a removable flashcard to a personal computer for storage and subsequent editing by an ECG technician. The subjects' physicians were sent a standard Holter report within 24 hr, which resulted in the identification of three subjects during the initial monitoring sessions who had experienced asymptomatic but potentially life-threatening arrhythmias. These patients underwent procedures to implant defibrillator/pacemaker devices and were dropped from the study; no additional recordings were undertaken for these three individuals. An additional subject was found to have continuous atrial fibrillation. None of these subjects' ECG data were included in the analysis. Thus, of the initial 23 subjects, we had multiple ECG recordings from 19 for the analysis.

Ambient pollutant data consisted of continuous measurements of PM~10~, PM~2.5~, and ozone, which were monitored at fixed-site stations operated by the SCAQMD in Indio and Palm Springs, located at either end of the population corridor in Coachella Valley. PM~10--2.5~ data were derived by subtracting PM~2.5~ mass concentrations from PM~10~. Although the SCAQMD also monitored for carbon monoxide and nitrogen dioxide during the study period, we did not use these data for our analysis because there were many days with missing values. Sulfur dioxide was not monitored in the valley at that time. We obtained daily meteorologic data collected at two valley airports (minimum, maximum, and mean temperature, as well as dew point, relative humidity, and barometric pressure) from the National Climatic Data Center (Asheville, NC).

Data from baseline questionnaires, medical records abstraction, pulmonary function testing, daily diaries, and extracted HRV variables were entered into a SAS database, with 10% double-data entry to check for accuracy. The database was then merged with air quality and meteorologic data for analysis using SAS (version 8; SAS Institute Inc., Cary, NC).

Data analysis
-------------

Only normal sinus R-R intervals were used in the HRV analysis. Artifacts, ectopy (both supraventricular and ventricular), and uninterpretable complexes were excluded. We examined time-domain, frequency-domain, and geometric HRV variables. Time-domain variables included *a*) the standard deviation of normal sinus rhythm ("normal-to-normal" or N-N) beats (SDNN), representing the average of the standard deviations of normal beats of successive 5-min blocks over the duration of the monitoring period (SDNN estimates overall HRV); *b*) the standard deviation of the average N-N intervals (SDANN) within successive 5-min blocks (an estimate of long-term components of HRV); and *c*) the root mean square of successive differences (r-MSSD), which is the square root of the mean of the sum of the squares of differences between adjacent normal R-R intervals, which estimates short-term components of HRV and is a sensitive indicator of vagal tone ([@b33-ehp0114-001215]).

Frequency-domain analysis delineates the heart rate signal into its frequency components and quantifies them in terms of their relative intensity or power. We examined three frequency-domain variables: high frequency (HF), low frequency (LF), and total power. HF components (0.15--0.40 Hz) provide an index of parasympathetic activity, whereas LF components (0.04--0.15 Hz) are considered to encompass both sympathetic and parasympathetic activity ([@b7-ehp0114-001215]; [@b33-ehp0114-001215]). Total power is an indicator of overall HRV.

Geometric methods involve analysis of the sample density histogram of R-R interval durations. A plot of the distribution typically depicts the main peak as a triangular shape. The triangular index (TRII) provides an estimate of overall HRV that is more resistant to beat-labeling errors than are its time- and frequency-domain counterparts ([@b33-ehp0114-001215]).

Because the Holter software did not allow for downloading time-domain HRV variables for monitoring periods other than the full 24 hr, we chose specific time intervals for which the HRV variables would be calculated and then extracted them manually into the database. For time-domain variables and the TRII, we chose 0600--0800 hr, 1800--2000 hr, and 24 hr. The two 2-hr intervals were selected to provide the most marked contrasts in ambient PM levels, which tended to be lowest in the early morning and highest in the early evening, based on examination of 24-hr continuous monitoring data from Palm Springs and Indio.

Frequency-domain variables generally are measured in 5-min increments and are sensitive to physical activity patterns. Therefore, to reduce intersubject behavioral variability, we chose to examine two 5-min periods: *a*) minutes 6--10 of the Holter monitoring session, during which the subjects were supine after the hook-up; and *b*) 0301--0305 hr, when most individuals would be asleep.

In summary, for each individual monitoring day, we obtained SDNN, SDANN, r-MSSD, and TRII for the full 24-hr period and for two 2-hr periods in the morning and evening, as well as frequency-domain HRV variables for two 5-min intervals.

Statistical methods
-------------------

Most of the HRV variables were log-normally distributed and were log-transformed for the analyses. We applied mixed linear regression models to the continuous HRV variables and pollution metrics, with random-effects parameters to control for interindividual variation and fixed-effects parameters to estimate relationships between the various pollutant metrics and changes in HRV.

We explored the independent influence of meteorologic factors, examining both concurrent and lagged values (up to 3 days) of temperature, humidity, dew point, and barometric pressure. Because only barometric pressure was associated with HRV metrics, it was retained in subsequent models. Air pollutant variables were entered individually into the models; we examined the impact of both concurrent and lagged pollutant values to allow for the possibility of delayed and cumulative effects. Therefore, for the 24-hr measures of HRV, single-day lags and moving averages of up to 4 previous days for each pollutant were considered. For HRV variables measured on a 2-hr (time domain and TRII) or 5-min (frequency domain) basis, we examined 2-, 4-, 6-, 8-, and 24-hr pollutant moving averages. Because HRV is related inversely to heart rate, the models included the subjects' average heart rate during the monitoring periods.

For some of the associations found, we conducted additional analyses to examine potential impacts of behavioral factors that might influence exposure. For example, for the 2-hr evening period, we examined the effect (based on responses in the daily diary) of subjects' keeping windows open, using AC, or being outdoors for \> 1 hr. Each of these factors was included separately as a dichotomous variable in models that also included a PM metric (PM~10~, PM~10--2.5~, or PM~2.5~). We also added an interaction term between the specific factor and the PM metric to these models (e.g., the use of AC between 1800 and 2000 hr and concurrent PM~10~).

Results
=======

[Table 1](#t1-ehp0114-001215){ref-type="table"} presents demographic and medical data for the 19 participants. The average number of HRV monitoring sessions per subject was 8.8 (range, 4--12). Descriptive statistics for the pollutant and meteorologic variables during the study period are presented in [Table 2](#t2-ehp0114-001215){ref-type="table"}, and the time- and frequency-domain HRV variables used in the analysis are summarized in [Table 3](#t3-ehp0114-001215){ref-type="table"}.

Evaluation of potential time-variant confounders through both simple correlation analysis and univariate regressions indicated that the pollutant variables were not confounded by any meteorologic variables. Although barometric pressure was often associated with the HRV measures, it had little impact on the associations of ambient pollutants with HRV. Therefore, the results presented are from fixed-effects models that included only the pollutant term and average heart rate as predictor variables.

Results of the analysis of time-domain HRV variables measured during the evening period (1800--2000 hr) are displayed in [Table 4](#t4-ehp0114-001215){ref-type="table"}. These results indicated associations between decrements in SDNN, SDANN, and TRII in relation to increases in both PM~10~ and PM~10--2.5~. The magnitude of the associations between SDNN and PM~10~ or PM~10--2.5~ increased as the averaging time increased up to 6 hr but began to decrease at 8 hr and diminished to nonsignificance when the averaging time was extended to the prior 24 hr. A similar pattern was observed for SDANN, whereas for TRII the coefficients for both PM~10~ and PM~10--2.5~ continued to increase modestly at 8 hr relative to an averaging time of 6 hr. There was no evidence of an association between PM~2.5~ or ozone and these HRV variables. There was no association between any pollutant variable and r-MSSD, except for a marginally significant but positive association with PM~10--2.5~ averaged over the preceding 24 hr.

In contrast to the regressions for the evening monitoring period, there were few associations during the morning monitoring period between pollutant metrics and time-domain variables (data not shown). PM~10--2.5~ was associated with both SDNN and SDANN at lags up to 4 hr but not at 24 hr. PM~10~, PM~2.5~, and ozone were not associated with any HRV metrics in the morning session. In addition, there was again a marginally significant positive association between PM~10--2.5~ averaged over 24 hr and r-MSSD.

Analysis of the frequency-domain variables during sleep (0300 hr) also indicated sporadic associations between HRV and PM metrics ([Table 5](#t5-ehp0114-001215){ref-type="table"}). For this monitoring period, the unlagged pollutant variables were measured over the prior hour (i.e., 0200--0300 hr). Total power was associated with all three particulate metrics. The strongest associations for PM~10~ and PM~10--2.5~ were averaged over the prior 4 hr, whereas for PM~2.5~, only the measurement in the prior hour was statistically significant. There were also several modest associations with changes in the HF and LF components, with no obvious patterns. Ozone was also associated with decreases in all three frequency-domain measures, although the coefficients were of borderline significance (*p* = 0.08 to 0.10). The daytime posthookup frequency-domain variables also showed no pattern of association with the pollutant metrics (data not shown).

Adding variables representing exposure-related behaviors (e.g., use of AC) to the models generally resulted in modest increases in the magnitude and significance of the coefficients for PM~10~ and PM~10--2.5~ (data not shown). However, neither these behavioral variables nor the interactive term coefficients were statistically associated with the HRV metrics. The use of exposure adjustment factors did not alter the generally null to modest findings for PM~2.5~.

Several constitutional and clinical variables \[age, sex, lung function, use of beta-blockers or angiotensin-converting enzyme (ACE) inhibitors, prior smoking status\] did not exhibit an association with SDNN, nor did they have much, if any, effect on the magnitude or significance of PM~10--2.5~ coefficients. In contrast, inclusion of LVEF in the model increased the absolute magnitude of the PM~10--2.5~ coefficient by 36% \[from −0.00072 (*p* = 0.02) to −0.00098 (*p* = 0.007)\], whereas the LVEF coefficient was of borderline statistical significance (*p* = 0.09).

Discussion
==========

We found consistent associations of several PM metrics, notably PM~10~ and PM~10--2.5~, with short-term decrements in several measures of HRV in a panel of older adults with coronary artery disease. The strongest associations were detected when PM measurements were taken within a few hours before the HRV measures. These associations, however, were no longer present when the PM averaging time was extended to 24 hr or longer. These observations suggest that if there are causal relationships between PM exposures and decreases in HRV, the effects likely occur in close temporal proximity to the exposures.

These findings accord with some previous epidemiologic studies of HRV ([@b11-ehp0114-001215]; [@b25-ehp0114-001215]), although others have reported more prolonged effects ([@b9-ehp0114-001215]; [@b26-ehp0114-001215]). [@b11-ehp0114-001215] conducted 25-min ECG measurements in 21 older Boston residents weekly over a 3-month period. They reported significant associations of r-MSSD and SDNN with PM~2.5~ within a few hours of obtaining the ECG data. No associations between PM~2.5~ and HRV were seen at lags longer than 24 hr. In a subsequent study, however, the same researchers found somewhat stronger associations with 24-hr PM metrics than with 4-hr averages ([@b30-ehp0114-001215]). [@b26-ehp0114-001215] reported decrements in several HRV metrics associated with 24-hr averages of PM~2.5~ measured up to 2 days before Holter monitoring, although the strongest associations were with same-day measurements. A recent study of 10 elderly subjects involving 2-hr controlled exposures to either filtered air or concentrated PM~2.5~ also reported significant decrements in several HRV measures immediately postexposure, which tended to persist (albeit somewhat attenuated) at 24 hr postexposure ([@b10-ehp0114-001215]). In contrast, other investigators found that a 48-hr PM averaging time had the strongest associations with decrements in HRV ([@b23-ehp0114-001215]).

In our study population of individuals with coronary artery disease, we identified PM-associated decreases in SDNN, SDANN, and TRII, but little relationship with r-MSSD. Others have found decrements in SDNN and SDANN, with mixed results regarding r-MSSD ([@b27-ehp0114-001215], [@b26-ehp0114-001215]). It is possible that the variable results with the latter metric are caused partly by the effects of a variety of common cardiovascular medications on r-MSSD. [@b16-ehp0114-001215] examined HRV in 26 elderly residents of a Baltimore retirement home, reporting significant decreases in HF, LF, and SDNN in relation to indoor and outdoor PM~2.5~ only among subjects with preexisting cardiovascular disease. Recently, [@b30-ehp0114-001215] reported stronger associations of PM~2.5~ (especially black carbon) with HRV decrements in subjects with a prior myocardial infarction (*n* = 3) relative to the other subjects (*n* = 25), although this observation must be interpreted cautiously because of small numbers. Other studies have reported that subjects with cardiovascular disease may be at increased risk of PM-associated changes in HRV ([@b14-ehp0114-001215]; [@b23-ehp0114-001215]). [@b14-ehp0114-001215] reported decrements in HF and LF variables among 34 elderly nursing home residents with both PM~2.5~ and ozone in Mexico City, especially among individuals with hypertension. However, we found little relationship between frequency-domain variables and either of these pollutants, nor did we observe that a history of hypertension affected the PM--HRV associations. However, the levels of both PM~2.5~ and ozone were substantially greater in the Mexican study (means of 37.2 μg/m^3^ PM~2.5~ and 149 ppb ozone in Mexico City vs. 18.6 μg/m^3^ and 37 ppb, respectively, in our study, representing the averages of the values recorded at Indio and Palm Springs). In addition, all of the subjects in our study had documented coronary artery disease, which could represent a more important determinant of susceptibility compared with hypertension alone.

Direct comparisons of our quantitative results with those of prior air pollution--HRV investigations are not entirely appropriate because they involve multiple differences in study design (e.g., various pollutant mixtures, averaging times for both pollution and HRV, exposure scenarios, subjects' health status and medications, and Holter monitoring protocols). Nevertheless, our results suggest associations of HRV metrics with PM exposures of the same order of magnitude as several of those previously reported ([Table 6](#t6-ehp0114-001215){ref-type="table"}), although not all studies have identified a relationship between PM and HRV.

In contrast to prior studies, however, the strongest signals that we identified were associated with PM~10--2.5~ of primarily geologic origins, which dominate the PM~10~ mass in the Coachella Valley, as well as throughout much of the arid American West and Southwest. A chemical mass balance analysis of annual average particle composition in Indio conducted previously by the [@b28-ehp0114-001215] indicated that geologic and vehicular sources contributed approximately 59% and 8% of PM~10~ mass, respectively, with high particulate metal concentrations of silicon, aluminum, iron, and calcium, markers of crustal sources. That we found associations of PM~10--2.5~ with HRV decrements whereas others (e.g., [@b16-ehp0114-001215]) did not may be a dose-related phenomenon: PM~10--2.5~ levels were substantially higher in this study than in any of the other investigations. Even within our study, we identified stronger, more consistent associations with the evening than with the morning PM concentrations (mean PM~10--2.5~ levels of 47.1 μg/m^3^ and 18.3 μg/m^3^ for the 2-hr evening and morning periods, respectively), suggesting a concentration-related effect. In addition, PM~10--2.5~ composition in the valley likely differs from those found in urban settings. It is also possible that at least some of the particles of interest lie in the intermodal size range (where the PM~2.5~ and PM~10--2.5~ distributions overlap).

Several publications link ambient PM~10--2.5~ with cardiovascular mortality ([@b6-ehp0114-001215]; [@b18-ehp0114-001215]; [@b20-ehp0114-001215]) and morbidity ([@b34-ehp0114-001215]). A recent review of the limited epidemiologic evidence found support for associations between PM~10--2.5~ and cardiorespiratory morbidity and mortality ([@b5-ehp0114-001215]). Toxicologic studies also indicate that some PM~10--2.5~ may be at least as capable of eliciting proinflammatory effects and oxidative damage as PM~2.5~ ([@b19-ehp0114-001215]; [@b29-ehp0114-001215]). Although particles may initiate or enhance inflammatory processes in the airways, the HRV changes indicated by our results and those of others ([@b11-ehp0114-001215]; [@b25-ehp0114-001215]) occurred over a time course shorter than that typically linked with pollutant-induced inflammation, suggesting perhaps direct involvement of neural reflexes. Consistent with this observation are the results of a recent controlled exposure study of asthmatic and healthy young adults ([@b12-ehp0114-001215]), in which concentrated PM~10--2.5~ exposures resulted in modest decrements in HRV with no evidence of airway inflammation in induced sputum or changes in exhaled nitric oxide. Using a PM~10--2.5~ concentrator, [@b12-ehp0114-001215] found reductions in several HRV measures in four healthy adults exposed for 2 hr to concentrations ranging from 46 to 197 μg/m^3^. Although the sample size was quite small, that investigation provides a modest degree of corroboration of our findings.

That we found sporadic and relatively weaker associations of HRV decrements with PM~2.5~ is somewhat puzzling, because the ambient PM~2.5~ concentrations in our study over-lapped with those in several other investigations ([@b11-ehp0114-001215]; [@b16-ehp0114-001215]). However, the specific composition and sources of the particles may be important determinants of response. [@b30-ehp0114-001215] found that the black carbon fraction of PM~2.5~ showed a stronger relationship with decrements in frequency- and time-domain HRV variables than did secondary particles (e.g., sulfates), although the latter were not measured directly in that analysis. In contrast, in a study of 34 elderly subjects in Seattle, Washington, where residential wood combustion is an important source of PM~2.5~, [@b31-ehp0114-001215] found no association of several frequency-domain HRV variables with 1-hr, 4-hr, or 24-hr measurements of ambient or indoor PM~2.5~. However, in that study, concentrations were low relative to those in other epidemiologic studies, and there was limited variability in exposure (median interquartile range was 6 μg/m^3^); thus, the extent to which wood combustion or other sources might have influenced these results cannot be determined. In a study of 39 boiler-makers exposed to PM~2.5~ occupationally, [@b17-ehp0114-001215] reported significant associations of PM-associated vanadium and lead with increases in the SDNN index after adjusting for mean heart rate, age, and smoking status, suggesting that specific particulate metals may affect cardiac autonomic activity.

Having detected consistent associations between PM metrics and several HRV variables in this population of individuals with preexisting cardiovascular disease, we did not identify any subject characteristics, except LVEF, associated with heightened susceptibility to PM. However, with only 19 subjects, this secondary analysis can only be considered exploratory. Moreover, LVEF was strongly correlated with average heart rate (*r* = 0.46, *p* \< 0.0001), which is inversely related to HRV.

Conclusions
===========

In this study of elderly subjects with documented coronary artery disease, we detected decrements in several HRV metrics that were consistently associated with elevated PM~10~ and PM~10--2.5~ concentrations. Associations of these HRV variables with PM~2.5~ levels were generally much weaker. The magnitude of the associations (\~1--4% decrease in HRV metrics per 10-μg/m^3^ increase in PM~10~ or PM~10--2.5~) was comparable with those observed in other studies of PM~2.5~ in urban areas. In arid environments characteristic of much of the American West and Southwest, elevated levels of ambient PM~10--2.5~ may adversely affect HRV in older subjects with coronary artery disease.

The clinical significance of PM-associated HRV decrements remains to be established. Most studies linking decreases in HRV with increased mortality have examined 24-hr baseline HRV as a predictor of adverse events over the course of months to years. Although these and others' results may offer a partial mechanistic explanation for the repeated observations in time-series studies of PM-associated cardiovascular mortality, it is also possible that such acute decrements in HRV represent an epiphenomenon of some other unmeasured, underlying pathophysiologic processes.
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###### 

Characteristics of HRV study population (*n* = 19).

  Characteristic              Value
  --------------------------- -------------
  Age (years)                 71.3 ± 6.0
  Sex (no.)                   
   Male                       12
   Female                     7
  Smoking status (no.)        
   Never                      7
   Former                     12
  Cardiac medications (no.)   
   Beta blockers              9
   ACE inhibitors             7
   Calcium channel blockers   2
  Lung function (mean ± SD)   
   FEV~1~ (L)                 2.17 ± 0.58
   FVC (L)                    3.01 ± 0.85
   FEF~25--75%~ (L/sec)       1.83 ± 0.98
   FEV~1~/FVC                 0.77 ± 0.02
   FEF~25--75%~/FVC           0.64 ± 0.37
  LVEF (mean ± SD)            47% ± 17

Abbreviations: FEF~25--75%~, mean forced expiratory flow between 25% and 75% of the FVC; FEV~1~, forced expiratory volume at 1 sec; FVC, forced vital capacity; LVEF, left ventricular ejection fraction.

###### 

Descriptive statistics of pollutant and meteorologic variables.

  Pollutant or meteorologic variable   Mean (range)
  ------------------------------------ --------------------
  PM~10~ (μg/m^3^, 24-hr average)      
   Indio                               46.1 (11.8--289.2)
   Palm Springs                        31.0 (9.0--140.3)
  PM~2.5~ (μg/m^3^, 24-hr average)     
   Indio                               23.2 (6.3--90.4)
   Palm Springs                        14 (4.7--52)
  Ozone (ppb, 1-hr maximum)            
   Palm Springs                        41 (19--92)
   Indio                               33 (12--66)
  Maximum temperature (°F)             69.6 (49.8--88.4)
  Relative humidity (%)                44.2 (13.7--85.5)
  Barometric pressure (mb)             29.4 (29.2--29.7)
  Precipitation (in)                   0.0006 (0--0.010)

###### 

Summary of HRV variables[a](#tfn2-ehp0114-001215){ref-type="table-fn"} and average heart rate.

  Variable (unit)                  No.   Mean ± SD
  -------------------------------- ----- ---------------
  SDNN (msec)                      168   73.2 ± 29.3
  SDANN (msec)                     168   53.9 ± 22.8
  R-MSSD (msec)                    168   44.1 ± 42.5
  TRII                             168   17.2 ± 6.1
  Total power (msec^2^)            169   1,216 ± 1,915
  HF (msec^2^)                     169   304 ± 818
  LF (msec^2^)                     169   221 ± 332
  Average heart rate (beats/min)   168   76 ± 13

Time domain variables, TRII, and average heart rate were measured 1800--2000 hr. Frequency domain variables were measured at 0300 hr.

###### 

Regression coefficients[a](#tfn3-ehp0114-001215){ref-type="table-fn"} for time-domain HRV variables measured in the evening (1800--2000 hr) in relation to different averaging times for PM~10~, PM~10--2.5~, and PM~2.5~.

                   SDNN            SDANN   TRII                                    
  ---------------- --------------- ------- --------------- ------- --------------- -------
  PM~10~                                                                           
   1800--2000 hr   −0.71 (0.268)   0.009   −0.99 (0.366)   0.008   −0.72 (0.252)   0.005
   1600--2000 hr   −1.03 (0.433)   0.019   −1.38 (0.590)   0.021   −1.1 (0.406)    0.008
   1400--2000 hr   −1.45 (0.54)    0.008   −1.80 (0.738)   0.016   −1.41 (0.51)    0.007
   1200--2000 hr   −1.31 (0.60)    0.031   −1.53 (0.821)   0.064   −1.46 (0.563)   0.011
   24 hr           −0.51 (0.77)    0.510   −0.71 (1.072)   0.51    −1.00 (0.725)   0.17
  PM~10--2.5~                                                                      
   1800--2000 hr   −0.72 (0.296)   0.017   −0.96 (0.444)   0.034   −0.61 (0.303)   0.046
   1600--2000 hr   −1.19 (0.516)   0.024   −1.53 (0.765)   0.049   −0.89 (0.531)   0.096
   1400--2000 hr   −1.84 (0.649)   0.006   −2.37 (0.986)   0.019   −1.23 (0.691)   0.080
   1200--2000 hr   −1.4 (0.767)    0.074   −2.02 (1.159)   0.087   −1.62 (0.833)   0.056
   24 hr           0.23 (0.923)    0.81    0.42 (1.433)    0.77    −0.37 (1.148)   0.75
  PM~2.5~                                                                          
   1800--2000 hr   −0.37 (1.01)    0.72    −1.26 (1.375)   0.36    −0.76 (0.957)   0.43
   1600--2000 hr   −0.55 (1.176)   0.64    −1.66 (1.60)    0.30    −0.55 (1.087)   0.61
   1400--2000 hr   −1.21 (1.034)   0.24    −1.74 (1.391)   0.21    −0.43 (0.956)   0.65
   1200--2000 hr   −1.25 (1.122)   0.27    −1.54 (1.429)   0.28    −0.26 (1.018)   0.80
   24 hr           −1.63 (2.36)    0.49    −3.20 (3.153)   0.31    −0.96 (2.129)   0.65

All coefficients and SE × 1,000. Regression model includes pollutant variable and average heart rate. Coefficient represents relationship between exposure and ln(SDNN) in msec.

###### 

Regression coefficients for frequency-domain HRV variables in relation to PM metrics and ozone.

                Total power       HF     LF                                         
  ------------- ----------------- ------ ----------------- ------ ----------------- ------
  PM~10~        −4.48 (2.732)     0.13   0.593 (2.829)     0.83   −3.40 (2.493)     0.17
   2 hr         −6.35 (3.479)     0.07   −0.12 (3.612)     0.98   −4.66 (3.177)     0.15
   4 hr         −8.10 (3.546)     0.02   −1.62 (3.684)     0.66   −5.65 (3.239)     0.08
   24 hr        −1.14 (3.192)     0.72   −4.02 (3.156)     0.21   0.293 (3.004)     0.92
  PM~2.5~       −11.00 (5.017)    0.03   3.112 (5.252)     0.55   −7.90 (4.642)     0.09
   2 hr         −7.28 (4.588)     0.12   3.884 (4.757)     0.42   −5.28 (4.249)     0.22
   4 hr         −6.45 (4.619)     0.17   5.111 (4.774)     0.29   −4.78 (4.263)     0.27
   24 hr        −1.84 (7.733)     0.81   15.84 (8.480)     0.07   0.794 (7.403)     0.92
  PM~10--2.5~   −4.61 (3.533)     0.20   −0.36 (3.469)     0.92   −3.38 (3.202)     0.29
   2 hr         −6.16 (5.109)     0.23   1.794 (5.077)     0.73   −4.05 (4.795)     0.40
   4 hr         −13.60 (6.438)    0.04   −3.51 (6.244)     0.58   −8.69 (5.964)     0.15
   24 hr        −1.02 (4.824)     0.84   −4.04 (4.483)     0.38   −1.37 (4.213)     0.75
  Ozone         −82.80 (63.03)    0.19   −106.60 (62.09)   0.09   −77.92 (58.73)    0.19
   8 hr         −147.40 (88.37)   0.10   −45.52 (91.09)    0.62   −145.70 (82.15)   0.08

All coefficients and SE × 1,000. PM~10~ indicates PM~10~ levels measured in the hour just before the HRV measurement (0300 hr); PM~10~ 2 hr indicates PM~10~ levels measured in the 2 hr before the HRV measurement, and so forth. Similar conventions apply to PM~2.5~, PM~10--2.5~, and ozone, except that ozone 8-hr indicates 8-hr averaged ozone levels (1900 hr--0300 hr).

###### 

Comparisons of particle-associated decreases in SDNN per 10 μg/m^3^ increase in PM.

  Reference               Mean of SDNN (averaging time)   PM metric (averaging time)   Effect estimate \[msec (95% CI)\]                                  Percent change
  ----------------------- ------------------------------- ---------------------------- ------------------------------------------------------------------ ----------------
  [@b27-ehp0114-001215]   129.6 (24 hr)                   PM~10~ (24 hr)               −1.8 (−1.1 to −2.5)                                                −1.4
  [@b11-ehp0114-001215]   72.7 (25 min)                   PM~2.5~ (4 hr)               −2.6 (−0.8 to −4.4)                                                −3.6
  [@b25-ehp0114-001215]   74.7 (1.75 hr)                  RSP (1.75 hr)                −1.1 (−0.5 to −1.7)                                                −1.5
  [@b26-ehp0114-001215]   131.4 (24 hr)                   PM~2.5~ (24 hr)              −3.5 (−1.9 to −5.1)                                                −2.7
  [@b23-ehp0114-001215]   31.6 (4 min)                    PM~2.5~ (24 hr)              −0.9 (−3.0 to 1.4)                                                 −2.8
  [@b31-ehp0114-001215]   49 (20 min)                     PM~2.5~ (24 hr)              0.5 (−2.4 to 3.9)[a](#tfn6-ehp0114-001215){ref-type="table-fn"}    1.0
  [@b8-ehp0114-001215]    33.9 (16 hr)                    PM~2.5--1~ (4 hr)            −1.4 (−3.0 to 0.2)[a](#tfn6-ehp0114-001215){ref-type="table-fn"}   −4.2
  Present study           73.2 (2 hr)                     PM~10~ (2 hr)                −1.2 (−0.3 to −2.1)                                                −1.6
  Present study           73.2 (2 hr)                     PM~10~ (6 hr)                −2.4 (−0.7 to −4.1)                                                −3.3
  Present study           73.2 (2 hr)                     PM~10--2.5~ (2 hr)           −1.2 (−0.2 to −2.2)                                                −1.6
  Present study           73.2 (2 hr)                     PM~10--2.5~ (6 hr)           −3.0 (−1.0 to −5.1)                                                −4.1

Abbreviations: CI, confidence interval; RSP, respirable particles (\< 3 μm) from environmental tobacco smoke.

Subjects with cardiovascular disease.
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